W.H.O. Backs Antibody Treatment For High-Risk Covid Patients September 24, 2021 Auto Bot Coronavirus (2019-nCoV), Regeneron Pharmaceuticals Inc, World Health Organization 0 The expensive treatment, developed by the U.S. drug maker Regeneron and the Swiss biotech company Roche, has garnered attention as backstop for those who shun vaccines.